New Oral Anticoagulants: An Overview

Sunita Aggarwal, Pooja Anand, Rashmi Mishra, Naresh Kumar

Abstract


Oral anticoagulant therapy is used in the prevention and treatment of venous thromboembolism (VTE), prevention of stroke and other systemic emboli in patients with atrial fibrillation (AF) and artificial heart valves.


Full Text:

PDF

References


Hinojar R, Jiménez-Natcher JJ, Fernández-Golfín C,

Zamorano JL. New oral anticoagulants: a practical guide

for physicians. European Heart Journal-Cardiovascular

Pharmacotherapy. 2015 Feb 25;1(2):134-45.

Heidbuchel H, Verhamme P, Alings M, Antz M,

Diener HC, Hacke W, Oldgren J, Sinnaeve P, Camm

AJ, Kirchhof P, Advisors:. Updated European Heart

Rhythm Association Practical Guide on the use of nonvitamin

K antagonist anticoagulants in patients with

non-valvular atrial fibrillation. EP Europace. 2015 Aug

;17(10):1467-507.

Raval AN, Cigarroa JE, Chung MK, Diaz-Sandoval LJ,

Diercks D, Piccini JP, Jung HS, Washam JB, Welch BG,

Zazulia AR, Collins SP. Management of Patients on non–

vitamin K antagonist oral anticoagulants in the acute

care and Periprocedural setting: a scientific statement

from the American Heart Association. Circulation. 2017

Mar 7;135(10):e604-33.

Clinical Excellence Commission, 2017, Non-vitamin

K Antagonist Oral Anticoagulant (NOAC) Guidelines,

Updated July 2017 Sydney: Clinical Excellence

Commission.

Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong

S, Eriksson H, Baanstra D, Schnee J, Goldhaber SZ.

Dabigatran versus warfarin in the treatment of acute

venous thromboembolism. New England Journal of

Medicine. 2009 Dec 10;361(24):2342-52.

Einstein Investigators. Oral rivaroxaban for symptomatic

venous thromboembolism. New England Journal of

Medicine. 2010 Dec 23;363(26):2499-510.

Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS,

Johnson M, Masiukiewicz U, Pak R, Thompson J, Raskob

GE, Weitz JI. Oral apixaban for the treatment of acute

venous thromboembolism. New England Journal of

Medicine. 2013 Aug 29;369(9):799-808.

Hokusai-VTE Investigators. Edoxaban versus

warfarin for the treatment of symptomatic venous

thromboembolism. New England Journal of Medicine.

Oct 10;369(15):1406-15.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2018 Journal of Advanced Research in Medicine (P-ISSN:2394-7047 & E-ISSN:2349-7181)